Overcoming Barriers and Advancing Precision in Colorectal Cancer Screening

In ‘Overcoming Barriers and Advancing Precision in Colorectal Cancer Screening,’ our experts delve into the ongoing challenges and future directions in colorectal cancer screening implementation. The discussion highlights persistent barriers to screening uptake, including access to care, follow-through after noninvasive testing, and disruptions caused by the COVID-19 pandemic. Faculty emphasize the value of patient navigation and mailed outreach programs in improving screening rates and closing care gaps. The conversation also examines how evolving technologies, including blood-based testing and machine learning–driven precision risk models, may reshape screening paradigms. Finally, the speakers consider the potential for risk-stratified approaches and evolving age recommendations as the field works toward more personalized and effective colorectal cancer prevention strategies.

Our next episode, ‘Individualizing When to Stop Colorectal Cancer Screening,’ features panelists discussing individualized decisions about when to stop colorectal cancer screening based on age, comorbidities, life expectancy, and patient preference, emphasizing shared decision-making, particularly for adults over 75 and those with limited life expectancy.